NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
0.8266
-0.0243 (-2.86%)
At close: May 15, 2026, 4:00 PM EDT
0.8431
+0.0165 (2.00%)
After-hours: May 15, 2026, 7:50 PM EDT
NeuroSense Therapeutics Market Cap
NeuroSense Therapeutics has a market cap or net worth of $29.22 million as of May 15, 2026. Its market cap has increased by 17.37% in one year.
Market Cap
29.22M
Enterprise Value
29.22M
1-Year Change
17.37%
Ranking
Category
Stock Price
$0.83
Market Cap Chart
Since the IPO on December 9, 2021, NeuroSense Therapeutics's market cap has decreased from $64.61M to $29.22M, a decrease of -54.77%. That is a compound annual growth rate of -16.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 29.22M | 27.94% |
| Dec 31, 2025 | 22.84M | -17.70% |
| Dec 31, 2024 | 27.75M | 158.68% |
| Dec 29, 2023 | 10.73M | -24.68% |
| Dec 30, 2022 | 14.24M | -46.24% |
| Dec 31, 2021 | 26.49M | -59.00% |
| Dec 9, 2021 | 64.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Daré Bioscience | 31.59M |
| Senti Biosciences Holdings | 31.46M |
| BriaCell Therapeutics | 30.28M |
| Lisata Therapeutics | 28.63M |
| Skye Bioscience | 28.58M |
| IGC Pharma | 28.26M |
| Barinthus Biotherapeutics | 27.76M |
| Polyrizon | 27.70M |